Galectin Therapeutics
GALT
#8627
Rank
C$0.18 B
Marketcap
$3.01
Share price
-0.71%
Change (1 day)
40.69%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of September 2024 : C$38.72 Million

According to Galectin Therapeutics's latest financial reports the company has C$38.72 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$25.22 M-50.07%
2021-12-31C$50.52 M46%
2020-12-31C$34.6 M-44.19%
2019-12-31C$62.01 M451.6%
2018-12-31C$11.24 M192.89%
2017-12-31C$3.83 M-81.41%
2016-12-31C$20.64 M-42.42%
2015-12-31C$35.85 M6.07%
2014-12-31C$33.8 M202.74%
2013-12-31C$11.16 M19.91%
2012-12-31C$9.31 M43.1%
2011-12-31C$6.5 M10.5%
2010-12-31C$5.88 M2129.68%
2009-12-31C$0.26 M-31.7%
2008-12-31C$0.38 M-70.62%
2007-12-31C$1.31 M-80.42%
2006-12-31C$6.72 M29.27%
2005-12-31C$5.19 M-59.56%
2004-12-31C$12.85 M30.27%
2003-12-31C$9.86 M225.24%
2002-12-31C$3.03 M27.74%
2001-12-31C$2.37 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.39 B 3,508.40%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.36 B 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA